Marcello Rotta is an Oncology physician affiliated with Colorado Blood Cancer Institute. OpenAlex indexes 61 publications with 1,828 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1721 E 19th Ave Ste 300
Denver
Denver, CO 802181258
Telephone
720-754-4800Provider last certified this registry record 26 Jul 2023.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202510 payments
- Astellas Pharma US IncProgram year20254 payments
- Daiichi Sankyo Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
93.7%CD38-directed Cytolytic Antibody45.4%Daratumumab100%Part B, office-administered≥27 patientsLeukocyte Growth Factor32.5%Tbo-filgrastim100%Part B, office-administered≥11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
3%Serotonin-3 Receptor Antagonist1.5%Ondansetron hydrochloride100%Part B, office-administered≥19 patientsOsmotically acting laxatives1.3%Magnesium sulfate100%Part B, office-administered≥22 patients+ 3 more classes in this area
Anti-infectives
1.2%Azole Antifungal0.5%Fluconazole62%Posaconazole38%Part D<11 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.3%Valacyclovir100%Part D≥14 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Luke Mountjoy, DO
Colorado Blood Cancer Institute
Alireza Eghtedar, MD
Colorado Blood Cancer Institute
Yazan Migdady, MD
Colorado Blood Cancer Institute
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”